EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development and translation of thiometallate sulfide donors using a porcine model of coronary occlusion and reperfusion

Thomas W Johnson, James Holt, Anna Kleyman, Shengyu Zhou, Eva Sammut, Vito Domenico Bruno, Charlotte Gaupp, Giacomo Stanzani, John Martin, Pietro Arina, Julia Deutsch, Raimondo Ascione und 2 weitere

Redox Biology · 2024

DOI: 10.1016/j.redox.2024.103167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Redox Biology, 2024. Verfasst von Thomas W Johnson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Translational Biomedical Research Centre (TBRC), Faculty of Health Science, University of Bristol, UK. Hauptthemen laut MEDLINE: Sulfides, Disease Models, Animal, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfide-releasing compounds reduce reperfusion injury by decreasing mitochondria-derived reactive oxygen species production. We previously characterised ammonium tetrathiomolybdate (ATTM), a clinically used copper chelator, as a sulfide donor in rodents. Here we assessed translation to large mammals prior to clinical testing. In healthy pigs an intravenous ATTM dose escalation revealed a reproducible pharmacokinetic/pharmacodynamic (PK/PD) relationship with minimal adverse clinical or biochemical events. In a myocardial infarction (1-h occlusion of the left anterior descending coronary artery)-reperfusion model, intravenous ATTM or saline was commenced just prior to reperfusion. ATTM protected the heart (24-h histological examination) in a drug-exposure-dependent manner (r2 = 0.58, p < 0.05). Blood troponin T levels were significantly (p < 0.05) lower in ATTM-treated animals while myocardial glutathione peroxidase activity, an antioxidant selenoprotein, was elevated (p < 0.05). Overall, our study represents a significant advance in the development of sulfides as therapeutics and underlines the potential of ATTM as a novel adjunct therapy for reperfusion injury. Mechanistically, our study suggests that modulating selenoprotein activity could represent an additional mode of action of sulfide-releasing drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfidesDisease Models, AnimalMyocardial Reperfusion InjuryAnimalsSwineCoronary OcclusionMyocardial InfarctionGlutathione PeroxidaseMyocardiumMaleMolybdenum

Stichwörter der Autor:innen

GasotransmitterIschaemiaMitochondriaReactive oxygen speciesReperfusion injurySelenoproteinTetrathiomolybdate

Substanzen

SulfidestetrathiomolybdateGlutathione PeroxidaseMolybdenum

Autor:innen und Institutionen

  • Translational Biomedical Research Centre (TBRC), Faculty of Health Science, University of Bristol, UK.
  • Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK.
  • Institute of Pharmaceutical Science, King's College London, London, UK; Centre for Pharmaceutical Medicine Research, King's College London, London, UK.
  • Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK. Electronic address: m.singer@ucl.ac.uk.
  • Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK; Institute of Pharmaceutical Science, King's College London, London, UK; Centre for Pharmaceutical Medicine Re…

Zitieren

APA

Johnson, T. W., Holt, J., Kleyman, A., Zhou, S., Sammut, E., Bruno, V. D., Gaupp, C., Stanzani, G., Martin, J., Arina, P., Deutsch, J., Ascione, R., Singer, M., & Dyson, A. (2024). Development and translation of thiometallate sulfide donors using a porcine model of coronary occlusion and reperfusion. Redox Biology. https://doi.org/10.1016/j.redox.2024.103167

Vancouver

Johnson TW, Holt J, Kleyman A, Zhou S, Sammut E, Bruno VD, et al. Development and translation of thiometallate sulfide donors using a porcine model of coronary occlusion and reperfusion. Redox Biology. 2024. doi:10.1016/j.redox.2024.103167

BibTeX
@article{Johnson2024,
  author = {Johnson, Thomas W and Holt, James and Kleyman, Anna and Zhou, Shengyu and Sammut, Eva and Bruno, Vito Domenico and Gaupp, Charlotte and Stanzani, Giacomo and Martin, John and Arina, Pietro and Deutsch, Julia and Ascione, Raimondo and Singer, Mervyn and Dyson, Alex},
  title = {Development and translation of thiometallate sulfide donors using a porcine model of coronary occlusion and reperfusion},
  journal = {Redox Biology},
  year = {2024},
  doi = {10.1016/j.redox.2024.103167}
}
Kostenlos starten →